Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Learn when bonds may outperform stocks for retirement, with practical timing cues and risk considerations.
24,889 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Ripple’s latest briefing argues passive Zcash holders remain protected if they did not trigger the exploit, even as m...
ARTY, the AI infrastructure ETF, surged as investors await the next round of hyperscaler capex guidance. The hypersca...
Casey’s General Stores prepares to report Q4 results after the bell, with analysts weighing margins in prepared foods...
If SpaceX goes public, the market could shift toward a new era of space commerce. This guide breaks down the three cr...
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
A wave of AI adoption is shifting from hype to daily practice, with firms treating AI as a strategic partner and buil...
SoFi Technologies has dropped about 42% over the last six months, trading near $16 as market conditions tighten. Anal...
Chevron stock has cooled from a $209 peak, leaving investors weighing dividend coverage, cash flow, and growth amid v...
Micron’s stock rise underscores ongoing memory-market strain as demand exceeds supply. Even Apple is feeling the impa...
A well-known reality TV figure reveals how convincing fake security texts lured him into a crypto scam that wiped out...
Billionaire investor Mark Cuban warns popular bets could quietly erode wealth as funding costs rise and consumer conf...